Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

AIM:TFW
AIM:TFWElectrical

3 Undiscovered UK Gems With Promising Potential

As the United Kingdom's FTSE 100 index experiences turbulence due to weak trade data from China, investors are increasingly turning their attention to smaller, potentially overlooked stocks that may offer resilience amid global economic uncertainties. In this environment, identifying promising small-cap companies with strong fundamentals and growth potential could be key for those looking to navigate the shifting market landscape.
LSE:GAMA
LSE:GAMATelecom

3 UK Dividend Stocks To Consider With Up To 5.1% Yield

In the wake of recent economic data from China, the FTSE 100 has experienced a downturn, highlighting the interconnectedness of global markets and their impact on UK indices. As investors navigate these turbulent waters, dividend stocks can offer a measure of stability and income potential, making them an attractive option for those seeking to balance risk with reward in uncertain times.
TASE:IBI
TASE:IBICapital Markets

A Look At I.B.I. Investment House (TASE:IBI) Valuation After Its Mixed 2025 Annual Results

I.B.I. Investment House (TASE:IBI) has drawn attention after reporting full year 2025 results, with revenue of ₪1,501.72 million and net income of ₪174.59 million, while earnings per share from continuing operations softened. See our latest analysis for I.B.I. Investment House. The earnings announcement appears to have come after a stretch of mixed share price momentum, with a 5.55% 7 day share price return and a 19.85% decline over 30 days, yet an 85.43% 1 year total shareholder return and...
NasdaqGS:HTHT
NasdaqGS:HTHTHospitality

H World Group (HTHT) Is Up 6.3% After Accelerating Its Asset-Light Expansion Plan - Has The Bull Case Changed?

In its recent Q4 2025 earnings call, H World Group Limited reported strong profit growth, solid cash generation, and an accelerated asset-light expansion plan that includes opening 2,200–2,300 hotels and closing 600–700 properties in 2026 to refine its portfolio. A key insight from this update is the increasing weight of fee-based franchise and manachised operations in H World’s earnings mix, underlining a pivot toward less capital-intensive growth. We will now examine how H World’s...
NYSE:ETR
NYSE:ETRElectric Utilities

Should Entergy’s US$10 Billion Meta Data Center Deal Reshape the Risk Playbook for ETR Investors?

In recent weeks, Entergy has secured Meta’s fully funded US$10.00 billion data center project, tying its Gulf Coast power network more closely to fast-growing AI-related electricity demand. This agreement not only concentrates a large, long-duration customer within Entergy’s service territory, but also highlights how hyperscale data centers can reshape utility capital planning, risk exposure, and long-term earnings profiles. With Meta’s massive data center commitment in place, we’ll now...
SEHK:6869
SEHK:6869Communications

A Look At Yangtze Optical Fibre And Cable (SEHK:6869) Valuation After Strong 2025 Results And Higher Final Dividend

Earnings jump and higher dividend put Yangtze Optical Fibre And Cable Limited (SEHK:6869) in focus Yangtze Optical Fibre And Cable Limited (SEHK:6869) has drawn attention after reporting full year 2025 results with higher sales, revenue and net income, alongside a raised final ordinary dividend announcement. See our latest analysis for Yangtze Optical Fibre And Cable Limited. At a latest share price of HK$189.0, Yangtze Optical Fibre And Cable Limited has seen strong momentum, with a 36.46%...
TSE:543A
TSE:543AMachinery

Assessing ARCHION (TSE:543A) Valuation After Recent Share Price Strength

Recent performance snapshot ARCHION (TSE:543A) has caught investor attention after a recent share price move, with the stock showing an 11.61% return over the past day and 34.11% over the past week. See our latest analysis for ARCHION. That sharp short term momentum sits against a mixed longer record, with strong recent share price returns over the past quarter and year to date contrasted with weaker multi year total shareholder returns. If you are looking beyond ARCHION for other transport...
NasdaqGS:BKR
NasdaqGS:BKREnergy Services

Is Baker Hughes’ Push Into Geothermal, LNG and AI Power Optimization Reshaping The Investment Case For BKR?

In late March 2026, XGS Energy and Baker Hughes announced collaborations spanning a 150-megawatt geothermal project in New Mexico, AI-enabled power optimization for data centers with Google Cloud, and critical LNG equipment for ST LNG’s planned offshore Texas export terminal. Taken together, these agreements underline how Baker Hughes is applying its turbomachinery, geothermal and digital power-management capabilities across LNG, renewable heat, and energy-hungry AI infrastructure...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is Nasdaq (NDAQ) Quietly Turning Its Core Infrastructure Into a Digital-Asset Moat?

On 23 March 2026, Nasdaq and Talos announced a partnership linking Talos’ digital asset infrastructure with Nasdaq’s Calypso and Trade Surveillance platforms to support integrated management of tokenized collateral and compliance monitoring for institutional clients. This collaboration highlights Nasdaq’s push to embed digital asset capabilities into mainstream risk, collateral, and market integrity systems, potentially unlocking currently trapped collateral and operational efficiencies for...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Did Ending the Galaxy Deal Just Reshape SharpLink’s (SBET) Capital Management Strategy?

SharpLink Gaming and Galaxy Digital Asset Management have mutually agreed to terminate their asset management agreement, with the termination scheduled to take effect on May 31, 2026, and the parties have already filed the required regulatory documentation. This marks a meaningful shift in SharpLink’s external asset management approach, potentially altering how it oversees and allocates capital within its broader gaming-focused operations. We will now examine how ending the Galaxy Digital...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Workday (WDAY) CEO Exit Amid Solid Results Is Testing Investor Confidence In Its AI-Era Strategy

In recent months, Workday reported double-digit revenue and subscription growth alongside expanding non-GAAP operating margins, while also announcing the resignation of CEO Carl Eschenbach following a mixed quarterly update. Despite these operational strengths, the combination of leadership uncertainty and investor concerns about enterprise software demand amid AI-driven workforce changes has become a key focus for the market. We’ll now explore how the CEO transition and shifting sentiment...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

StoneX Group (SNEX) Is Up 7.7% After Launching New Securitization And Ag-Tech Partnerships Has The Bull Case Changed?

In late March 2026, StoneX Group Inc. unveiled a series of initiatives, including partnerships with The Pathfinder Group and Bushel and the launch of a new Securitization Banking, Lending & Capital Markets platform, to expand its payments, structured finance, and grain merchandising capabilities. Together, these moves highlight how StoneX is knitting together technology-driven infrastructure across cross-border payments, institutional credit, and agricultural hedging workflows, potentially...
NasdaqGM:ATRC
NasdaqGM:ATRCMedical Equipment

A Look At AtriCure (ATRC) Valuation After Q4 Growth And Recent Analyst Downgrades

Why AtriCure (ATRC) Is Back on Investors’ Radar AtriCure (ATRC) drew fresh attention after reporting Q4 2025 earnings with 15% revenue growth, followed by share price pressure linked to a JPMorgan downgrade and a reduced price target from UBS. See our latest analysis for AtriCure. Despite the recent Q4 earnings momentum, AtriCure’s share price has been under pressure, with a 90 day share price return showing a 28.26% decline and a 1 year total shareholder return showing a 7.15% decline,...
NYSE:THG
NYSE:THGInsurance

A Look At Hanover Insurance Group’s (THG) Valuation After Recent Share Price Gains

Hanover Insurance Group (THG) continues to attract attention after recent share price moves, with the stock closing at US$176.10. Investors are weighing this level against the company’s returns, value score and profitability profile. See our latest analysis for Hanover Insurance Group. The recent 2.2% 1 day share price return and 4% 7 day share price return sit against a slightly weaker 90 day share price return of 2.4% decline. However, the 1 year total shareholder return of 14.1% and 3 year...
TSX:FRU
TSX:FRUOil and Gas

Assessing Freehold Royalties (TSX:FRU) Valuation After Record Production And U.S. Reserve Replacement Update

Record production update puts Freehold Royalties (TSX:FRU) in focus Freehold Royalties (TSX:FRU) drew fresh attention after reporting record 2025 production, supported by U.S. volume growth, a higher liquids mix and U.S. reserve replacement above 100%. Management flagged slower drilling in late 2025, with early 2026 output expected to soften before activity and volumes pick up again in the second half of the year. See our latest analysis for Freehold Royalties. Freehold Royalties’ record 2025...
NYSE:BORR
NYSE:BORREnergy Services

A Look At Borr Drilling (BORR) Valuation After New Global Jack Up Contract Wins

Borr Drilling (BORR) is back in focus after announcing fresh contract commitments and extensions for four premium jack up rigs across West Africa, the Americas, Europe, and Southeast Asia, expanding its contracted backlog. See our latest analysis for Borr Drilling. At a latest share price of US$5.83, Borr Drilling has seen a 46.5% 90 day share price return and a very large 1 year total shareholder return, suggesting momentum has been building alongside recent contract awards and fleet...
NYSE:BG
NYSE:BGFood

A Look At Bunge Global (BG) Valuation After Debt Offering, Buyback Plan And Protein Business Acquisition

Bunge Global (BG) has put capital allocation in the spotlight, announcing a $1.2b senior unsecured notes offering, a new $3b share repurchase program, and an acquisition of protein businesses from International Flavors & Fragrances. See our latest analysis for Bunge Global. The recent capital return announcements and protein acquisition come at a time when momentum is building, with a 30 day share price return of 10.93% and a 1 year total shareholder return of 82.26%. If you are weighing...
LSE:ACG
LSE:ACGMetals and Mining

3 Undervalued European Small Caps With Recent Insider Buying

As European markets experience a positive shift, with the STOXX Europe 600 Index rising by 3.92% amid hopes for a shorter Middle East conflict, small-cap stocks across the region are gaining renewed investor interest. In this environment, identifying promising stocks often involves looking at those with strong fundamentals and recent insider buying activity, which can signal confidence in their future performance.
SWX:SQN
SWX:SQNCapital Markets

European Market Gems 3 Stocks That May Be Priced Below Intrinsic Value Estimates

As European markets navigate through the complexities of Middle East tensions and energy market volatility, recent gains in indices like the STOXX Europe 600 and Germany’s DAX suggest a cautiously optimistic sentiment among investors. In such an environment, identifying stocks that may be priced below their intrinsic value can offer potential opportunities for those looking to capitalize on market inefficiencies.
SWX:KURN
SWX:KURNBiotechs

3 European Growth Stocks Insiders Own With Up To 58% Earnings Growth

As European markets show resilience with the STOXX Europe 600 Index rising by 3.92%, investor sentiment is buoyed by hopes of a shorter-than-expected Middle East conflict and robust gains in major indices like Germany’s DAX and the UK’s FTSE 100. In this environment, growth companies with high insider ownership can offer unique opportunities, as they often signal strong confidence from those closest to the business, aligning their interests with shareholders during volatile times.
ENXTPA:ALGAE
ENXTPA:ALGAEChemicals

European Penny Stocks: 3 Picks With Market Caps Over €40M

The European market has recently experienced a wave of optimism, with the STOXX Europe 600 Index climbing nearly 4% amid hopes for a shorter-than-expected conflict in the Middle East. As investors navigate these turbulent times, penny stocks—often seen as relics of past trading days—still present relevant opportunities for growth. These smaller or newer companies can offer significant returns when supported by strong financial health and solid fundamentals, making them an intriguing option...
CPSE:UIE
CPSE:UIEFood

Undiscovered Gems in Europe Three Promising Stocks for April 2026

As European markets navigate the complexities of Middle East tensions and energy market volatility, the pan-European STOXX Europe 600 Index has shown resilience, ending the week up 3.92% in local currency terms. This positive sentiment is supported by hopes for a shorter-lived conflict and is reflected in gains across major stock indexes like Germany's DAX and Italy's FTSE MIB. In this environment, identifying promising stocks involves looking for companies with strong fundamentals that can...
BIT:UNI
BIT:UNIInsurance

European Dividend Stocks To Watch In April 2026

As European markets experience a positive shift, with the STOXX Europe 600 Index climbing 3.92% amid hopes for a shorter-lived Middle East conflict, investors are increasingly turning their attention to dividend stocks as a potential source of stability and income. In such volatile times, companies that consistently pay dividends can offer an attractive option for those seeking to balance growth opportunities with reliable returns.
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

A Look At Ascendis Pharma (ASND) Valuation After Key TransCon Trial Successes And Yuviwel FDA Approval

Ascendis Pharma (NasdaqGS:ASND) has drawn fresh attention after positive Week 52 Phase 2 New InsiGHTS data for TransCon hGH in Turner syndrome and long term ApproaCH trial results for TransCon CNP in achondroplasia. On top of these trial updates, accelerated FDA approval for Yuviwel, the TransCon CNP treatment for achondroplasia, adds a new regulatory milestone that many investors are now weighing against Ascendis Pharma’s recent share performance. See our latest analysis for Ascendis...